, Tracking Stock Market Picks
Enter Symbol:
Rating: CPHD
Buy $47

Cepheid (NASDAQ: CPHD) reiterated to Buy with price target $47 by Needham

Wednesday,  Oct 14, 2015  8:25 AM ET by Dave Ficere

Cepheid (NASDAQ: CPHD) rated
Buy with price target $47 by Needham.

Cepheid, Inc. develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid, typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy